TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High

Benzinga Logo Benzinga By Vandana Singh
CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High

CVS Health reported strong Q3 earnings, beating analyst expectations with $102.87 billion in sales and raising its fiscal 2025 adjusted earnings guidance to $6.55-$6.65 per share.

Insights
CVS   positive

Exceeded quarterly revenue expectations, increased earnings guidance, reported revenue growth across all segments, and stock hit a 52-week high